Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes

Diabetologia

Volumn 43, Issue 11, 2000, Pages 1360-1367

  Gilbert, R E ^a   Kelly, D J ^a   Cox, A J ^a   Wilkinson Berka, J L ^a   Rumble, J R ^a   Osicka, T ^a   Panagiotopoulos, S ^a   Lee, V ^a   Hendrich, E C ^a   Jerums, G ^a   Cooper, M E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiotensin converting enzyme; Permeability; Retina; Vascular endothelial growth factor

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; EXPERIMENTAL MODEL; GENE OVEREXPRESSION; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETINA; STREPTOZOCIN DIABETES;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOTTING, NORTHERN; CAPILLARY PERMEABILITY; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION; IN SITU HYBRIDIZATION; LYMPHOKINES; MALE; PERINDOPRIL; RAMIPRIL; RATS; RATS, SPRAGUE-DAWLEY; RETINA; RETINAL VESSELS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033753370     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051539     Document Type: Article

References (66)

1. Retinopathy and vision loss in insulin dependent diabetes in Europe - The Eurodiab IDDM Complications Study
2. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy
3. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy
4. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
5. Renal reninangiotensin system in diabetes: Functional, immunohistochemical, and molecular biological correlations
6. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
7. The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension
8. Renin-containing muller cells of the retina display endocrine features
9. Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy
10. Angiotensin levels in the eye
11. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes
12. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells
13. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells
14. Triphasic changes in selectivity with increasing proteinuria in type I and type II diabetes
15. Enzymatic determination of glucose and fructose simultaneously
16. Glomerular filtration rate in the streptozocin diabetic rat: The role of exchangeable sodium, vasoactive hormones and insulin therapy
17. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction
18. Vascular hypertrophy in experimental diabetes: Role of advanced glycation end products
19. The mouse gene for Vascular Endothelial Growth Factor - Genomic structure, Definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatory sequences
20. SPARC gene expression is reduced in early diabetes related kidney growth
21. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes
22. Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat: Role of the reninangiotensin system
23. 33P
24. Localization of angiotensin II receptors in rat and monkey kidney by in vitro autoradiography
25. Amylin binding in rat renal cortex, stimulation of adenyl cyclase and activation of plasma renin
26. Effects of very mild versus overt diabetes on vascular hemodynamics and barrier function in rats
27. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat
28. Preparation of 131I-labelled human growth hormone of high specific radioactivity
29. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
30. Purification and NH-terminal amino acid sequence of guinea pigtumor-secreted vascular permeability factor
31. Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea
32. Vascular endothelial growth factor is a secreted angiogenic mitogen
33. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
34. The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas
35. Upregulation of vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat
36. Factors regulating the expression of vascular permeability/vascular endothelial growth factor by human vascular tissues
37. Advanced glycation end products increase retinal vascular endothelial growth factor expression
38. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro
39. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and supressed by an effective orally active β-isoform-selective inhibitor
40. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells
41. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells
42. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only
43. Insulin and insulin-like growth factor-i induce vascular endothelial growth factor mRNA expression via different signaling pathways
44. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor
45. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects
46. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat
47. Increased vascular permeability in spontaneously diabetic BB/W rats and in rats with mild versus severe streptozotocin-induced diabetes
48. Interaction between hypertension and diabetes on vascular function and structure in rats
49. Ocular vascular endothelial growth factor in diabetic rats are elevated before observable retinal proliferative changes
50. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate
51. Analysis by immunocytochemistry and in situ hybridization of the distribution of or renin and its mRNA in kidney, testis, adrenal, and pituitary of the rat
52. A comparative study of the distribution of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues
53. Angiotensin II in the rabbit retina
54. Angiotensinogen mRNA is synthesized locally in rat ocular tissues
55. Demonstration of renin mRNA, and Angiotensinogen mRNA, and Angiotensin Converting Enzyme mRNA Expression in the Human Eye - Evidence For an Intraocular Renin-Angiotensin System
56. Expression and localization of angiotensin ii type 1 receptor mRNA in rat ocular tissues
57. Quantitative receptor autoradiographic analysis for Angiotensin-II receptors in bovine retinal microvessels - Quantitation with radioluminography
58. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and zucker diabetic rats - The effect of angiotensin II on Na + ,K + -AtPase activity
59. Angiotensin converting enzyme inhibitor treatment for young normotensive diabetic subjects: A two-year trial
60. Protective effects of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy
61. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients
62. Increased incidence of retinopathy in diabetics with elevated blood pressure. A six-year follow-up study in Pima Indians
63. A cohort study of the relationship of diabetic retinopathy to blood pressure
64. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
65. Mechanical stretch induces vascular permeability factor in human mesangial cells: Mechanisms of signal transduction